The US giant will pay the money upfront for distribution rights for SSGJ-707 outside of China; the deal could be worth up to $4.8bn and Pfizer will also invest $100m into the HKEX listed firm.

Exports grew 15% in Q1, however there is expected to be a slowdown moving forward as tariffs bite, the baht remains strong and tourism faces headwinds.

Minority owner Partners Group said the IPO proceeds will be used to further grow the Hangzhou-headquartered restaurant's 493 outlets and establish a centralised food processing facility; Clifford Chance, Citi and CMB International Capital were involved in the deal.

The Japanese giant will make cost savings of ¥500bn and reduce its workforce by 20,000, and its number of plants from 17 to 10 by FY 2027, after a net loss of ¥670.9bn in FY 2024.

Clean energy investments are ramping up in Apac, but a $800bn annual shortfall risks slowing momentum. At Temasek’s Ecosperity Week, IFC's Riccardo Puliti and BlackRock's Susan Chan called for bolder partnerships, clearer policies, and better capital mobilisation.

China and the US will start high level trade talks on May 9 in Switzerland.

The agreement, which will reduce tariffs across billions of dollars of goods, comes after three years of talks.

The HKMA and CMU OmniClear are leading Hong Kong’s ambitions to internationalise the use of Chinese bonds in global trading. The development of the innovative infrastructure represents a breakthrough for Rmb repos, clearing, settlement and custody.

An April review by the IMF ended without an agreement, with June the next opportunity to meet the IMF's conditions and release two tranches of loans.

The Swedish firm has said that it is no longer providing financial guidance for 2025 and 2026, with job losses expected across its global workforce.